Apparent diffusion coefficient for differentiating between benign and malignant hepatic focal lesions
Open Access
- 10 December 2020
- journal article
- research article
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 10 (1) , 1-8
Abstract
Background: The aim of this study was to prospectively evaluate the role of diffusion weight MRI (DWI) in the characterization of hepatic focal lesions by using apparent diffusion coefficient (ADC). Thirty patients (18 women, 12 men; mean age 48.5 years) with hepatic focal lesions were included in this study. Patients underwent DW MR imaging with the SPLICE sequence. ADC of each focal lesion carcinoma was calculated from DW MR Images obtained with low and high b values. ADCs were compared among pathological types of focal lesions. Results: Among the 30 patients included in the study, 46 focal lesions were detected. Twenty-four lesions were metastatic lesions from primary cancer, 7 lesions were hepatocellular carcinoma (HCC), 9 lesions were hemangiomas, and 6 lesions were simple cysts. There was highly significant difference between the mean ADC of the malignant lesions (metastasis and HCC) and the mean ADC of benign lesions (hemangiomas and cysts). The ADC of malignant lesion was much less than that of benign lesion. The mean ADC of malignant lesions (n = 31) was 0.73 ± 0.19 × 10−3 mm2/s, and the mean ADC of benign lesions (n = 15) was 1.94 ± 0.68 × 10−3 mm2/s (p value < 0.001). There was no significant difference between the cysts and hemangiomas. There was no statistically significant difference between the metastases and hepatocellular carcinoma. Conclusion: ADCs values were able to differentiate benign from malignant lesions. ADC should be considered in the work up of patients with hepatic focal lesions.Keywords
This publication has 22 references indexed in Scilit:
- The role of ADC measurement in differential diagnosis of focal hepatic lesionsEuropean Journal of Radiology, 2012
- Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? NOEuropean Journal of Internal Medicine, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Diffusion weighted imaging in the liverWorld Journal of Gastroenterology, 2010
- Role of diffusion-weighted magnetic resonance imaging inthe differential diagnosis of focal hepatic lesionsWorld Journal of Gastroenterology, 2009
- Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncologyEuropean Radiology, 2008
- Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic reviewHepatology International, 2007
- Distinguishing benign from malignant liver tumoursCancer Imaging, 2007
- Diffusion-weighted magnetic resonance imaging and its application to cancerCancer Imaging, 2006
- α-fetoprotein and ultrasonography screening for hepatocellular carcinomaGastroenterology, 2004